Put Options

12 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$190.52 - $236.72 $3.43 Million - $4.26 Million
18,000 New
18,000 $4.17 Million
Q4 2022

Feb 14, 2023

SELL
$252.44 - $306.72 $19.1 Million - $23.2 Million
-75,500 Reduced 30.22%
174,300 $48.3 Million
Q3 2022

Nov 14, 2022

BUY
$194.69 - $268.46 $22.5 Million - $31 Million
115,500 Added 86.0%
249,800 $66.7 Million
Q2 2022

Aug 15, 2022

BUY
$187.54 - $223.02 $1.88 Million - $2.23 Million
10,000 Added 8.05%
134,300 $27.4 Million
Q1 2022

May 13, 2022

SELL
$193.77 - $244.14 $43.1 Million - $54.3 Million
-222,300 Reduced 64.14%
124,300 $26.2 Million
Q4 2021

Feb 11, 2022

BUY
$223.92 - $287.77 $8.37 Million - $10.8 Million
37,400 Added 12.1%
346,600 $83.2 Million
Q3 2021

Nov 12, 2021

BUY
$282.99 - $369.05 $39 Million - $50.9 Million
137,900 Added 80.5%
309,200 $87.5 Million
Q2 2021

Aug 16, 2021

BUY
$259.0 - $414.71 $31.4 Million - $50.2 Million
121,100 Added 241.24%
171,300 $59.3 Million
Q1 2021

May 17, 2021

BUY
$242.95 - $284.63 $1.51 Million - $1.76 Million
6,200 Added 14.09%
50,200 $14 Million
Q4 2020

Feb 16, 2021

SELL
$236.26 - $355.63 $6.88 Million - $10.3 Million
-29,100 Reduced 39.81%
44,000 $10.8 Million
Q3 2020

Nov 16, 2020

BUY
$264.77 - $305.71 $18.2 Million - $21 Million
68,800 Added 1600.0%
73,100 $20.7 Million
Q2 2020

Aug 14, 2020

BUY
$258.66 - $342.55 $1.11 Million - $1.47 Million
4,300 New
4,300 $1.15 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.